Hispanics With Metabolic Syndrome and Non-ischemic Heart Failure
NCT ID: NCT00804882
Last Updated: 2015-04-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2008-10-31
2009-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Incidence of Diabetes and Cardiovascular Disease in Mexican Americans
NCT00005205
Improving Prevention of Heart Disease in Latinos
NCT00101530
Cardiometabolic and Mental Health in the RGV
NCT03436875
Cardiovascular Risk Profile Among Mexican-Americans
NCT00005187
Cardiovascular Disease in FH Heterozygous
NCT01783405
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Mexican Americans with heart failure and metabolic syndrome
No interventions assigned to this group
2
Mexican Americans with heart failure without metabolic syndrome
No interventions assigned to this group
3
Non-Hispanic White Americans with heart failure and metabolic syndrome
No interventions assigned to this group
4
Non-Hispanic White Americans with heart failure without metabolic syndrome
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. known diagnosis of HF
3. complete 2-dimensional and Doppler echocardiogram within the last 12 months.
Exclusion Criteria
2. recent history (previous 6 months) of decompensated HF
3. heart transplant
4. diagnosis of diabetes (rationale: diabetes independently predicts HF)
5. race/ethnicity other than Mexican American or non-Hispanic white.
18 Years
59 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Health Resources and Services Administration (HRSA)
FED
Texas Tech University Health Sciences Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Texas Tech University Health Sciences Center
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rey P Vivo, MD
Role: PRINCIPAL_INVESTIGATOR
Texas Tech University Health Sciences Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Texas Tech University Health Sciences Center
Lubbock, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
L08-174
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.